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Abstract
Objective: We sought to evaluate the relationship between onchocerciasis prevalence and that of epilepsy using available
data collected at community level.
Design: We conducted a systematic review and meta-regression of available data.
Data Sources: Electronic and paper records on subject area ever produced up to February 2008.
Review Methods: We searched for population-based studies reporting on the prevalence of epilepsy in communities for
which onchocerciasis prevalence was available or could be estimated. Two authors independently assessed eligibility and
study quality and extracted data. The estimation of point prevalence of onchocerciasis was standardized across studies
using appropriate correction factors. Variation in epilepsy prevalence was then analyzed as a function of onchocerciasis
endemicity using random-effect logistic models.
Results: Eight studies from west (Benin and Nigeria), central (Cameroon and Central African Republic) and east Africa
(Uganda, Tanzania and Burundi) met the criteria for inclusion and analysis. Ninety-one communities with a total population
of 79,270 individuals screened for epilepsy were included in the analysis. The prevalence of epilepsy ranged from 0 to 8.7%
whereas that of onchocerciasis ranged from 5.2 to 100%. Variation in epilepsy prevalence was consistent with a logistic
function of onchocerciasis prevalence, with epilepsy prevalence being increased, on average, by 0.4% for each 10% increase
in onchocerciasis prevalence.
Conclusion: These results give further evidence that onchocerciasis is associated with epilepsy and that the disease burden
of onchocerciasis might have to be re-estimated by taking into account this relationship.
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Introduction
Recent surveys, based on rapid epidemiological mapping of
onchocerciasis (REMO), have revealed that the number of people
infected with Onchocerca volvulus, the causative agent of onchocer-
ciasis, had been largely underestimated. According to the latest
REMO results obtained as part of the African programme for
onchocerciasis control (APOC), 37 million are estimated to be
infected with O. volvulus in Africa [1]. Accordingly, the Disability
Adjusted Life Years (DALYs) lost per year due to onchocerciasis is
estimated to be 1.49 million. This number is threefold higher than
the previous figure published 2 years earlier [2] but probably still
underestimates the real burden of disease attributable to
onchocerciasis. The current DALY estimates account for blind-
ness, visual impairment and onchocercal itching due to skin
disease, yet it does not account for significant excess mortality due
to heavy infections with O. volvulus [3].
The excess mortality of sighted individuals with high microfi-
larial loads suggests the operation of insidious and systemic
involvement, neurologic involvement having been proposed as a
possible candidate [4]. In particular, a link between onchocerciasis
and epilepsy has been suspected since the 1930s [5]. Population-
wide surveys found significant correlations between prevalence of
epilepsy and that of onchocerciasis in Uganda [6] and between
www.plosntds.org 1 June 2009 | Volume 3 | Issue 6 | e461prevalence of epilepsy and community microfilarial load (CMFL)
of onchocerciasis in Cameroon [7]. However, case-control studies
evaluating the association between epilepsy and onchocerciasis
reached diverse conclusions: significant association was demon-
strated in areas where onchocerciasis prevalence exceeded 60%
[7,8], whereas no significant relationship was found in areas with
lower onchocerciasis prevalence [9,10,11].
The present work aims at testing the hypothesis that in
communities with high onchocerciasis endemicity, the prevalence
of epilepsy will clearly exceed that found in communities of low
onchocerciasis endemicity. We conducted a literature review of
epidemiological studies addressing the issue of the onchocerciasis-
epilepsy relationship and performed a meta-regression analysis
including available population-based data to quantify the
influence of onchocerciasis endemicity on the prevalence of
epilepsy.
Methods
Data sources and search strategy
We searched PubMed and ISI Web of Knowledge up to
February 2008, with neither past time limit nor language
restriction, to identify population-based studies reporting on the
prevalence of epilepsy in communities for which onchocerciasis
prevalence was available or such prevalence could be estimated.
We entered the following search terms and Boolean operators, for
matches under any field: epilep* AND onchocerc*, epilep* AND
country with country being iteratively one of the 11 OCP countries,
19 APOC countries, six OEPA countries, and Yemen. Titles and
available abstracts were scanned for relevance, identifying papers
requiring further consideration. Bibliographies of relevant articles
were checked. Relevant theses and reports were also searched at
the library of the Institut d’Epide ´miologie et de Neurologie Tropicale
(IENT, Limoges). The authors who initiated the study (SDSP &
MB) also contacted researchers who were requested to provide
information and/or data not included in the articles or other
documents.
Study selection
Studies were selected if both epilepsy prevalence and an
indicator of onchocerciasis prevalence were available or such
prevalence could be calculated. Inclusion criteria for subsequent
analysis were set to incorporate studies: (1) carried out following a
population-based design; (2) providing information on the
methods used to diagnose epilepsy and onchocerciasis and (3) in
which epilepsy prevalence was assessed in the general population,
i.e. both in children and adults. Study communities with a sample
of less than 10 subjects were discarded.
Data extraction
Two authors (SDSP, MB) independently assessed eligibility and
study quality, and extracted data. We recorded all basic
parasitological and demographic information from each eligible
study into a purpose-built database. The extracted data included
demographic characteristics of the population examined (age
range and sex), recruitment methods, and number and dates of
previous community treatments with ivermectin. For onchocerci-
asis, specific information was recorded on methods used for
parasitological examination. For epilepsy, details on sampling
procedures, and definition of epilepsy were recorded.
Quantitative data synthesis
To quantify the extent to which epilepsy prevalence is
associated with onchocerciasis endemicity across the different
studies, a meta-regression was performed. Epilepsy prevalence was
defined as the outcome and onchocerciasis prevalence as the
explanatory variable.
We used a logistic model to assess the relationship between
prevalence of epilepsy and that of onchocerciasis. A random effect,
capturing between-studies heterogeneity was subsequently incor-
porated into the model previously outlined. Significance of this
effect was tested using the likelihood ratio test [12]. Logistic
models were first estimated using the raw data collected during the
review of literature. Because we had some reasons to think that
some of the published data may have suffered from methodolog-
ical bias, we developed some correction factors to standardize the
data (see below). Logistic models (fixed-effect then random-effect
models) were then estimated from the corrected data.
In addition, in order to test whether the relationship between
prevalence of epilepsy and that of onchocerciasis was influenced
by a specific study, each study was successively omitted from the
whole database and the parameters re-estimated. Parameters of
the different models were estimated using the non-linear regression
procedure (NLMixed) provided in the SAS v8.1 software. This
procedure provides Bayes empirical estimates of the study-specific
random-effect [13].
Standardisation of onchocerciasis and epilepsy
prevalence
The prevalence of onchocerciasis was considered to have been
measured by a standard procedure if it has been estimated in the
general population ($5 years old) using the onchocerciasis
diagnostic method used by the Onchocerciasis Control Pro-
gramme in West Africa (OCP): this entails taking a skin biopsy
from each iliac crest, using a 2 mm Holth-type punch, and
incubating it for 24 h in normal saline before searching for the
presence of O. volvulus microfilariae [14]. Five of the eight studies
included in the analysis [6,8,15,16,17] used a method for the
diagnosis of infection with O. volvulus deviating from the OCP
standard procedure. Table 1 summarises the types of deviation
and the rationale for correction of the respective onchocerciasis
Author Summary
Epilepsy is particularly common in tropical areas. One main
reason is that many endemic infections have neurological
consequences. In addition, the medical, social and
demographic burden of epilepsy remains substantial in
these countries where it is often seen as a contagious
condition and where the aetiology is often undetermined.
For several decades, field researchers had reported some
overlapping between the geographical distributions of
epilepsy and onchocerciasis, a parasitic disease caused by
the filarial worm Onchocerca volvulus which afflicts some
40 million persons worldwide. Here, we conducted a
statistical analysis of all the data available on the
relationship between the two conditions to determine
whether the proportion of people suffering from epilepsy
in a community could be related to the frequency of
onchocerciasis. The combined results of the eight studies
carried out in west, central and east Africa indicate a close
epidemiological association between the two diseases.
Should a causative relationship be demonstrated, oncho-
cerciasis, which is known as ‘‘river blindness’’ because of its
most serious sequela and the distribution of its vectors,
could thus also be called ‘‘river epilepsy’’. More research is
needed to determine the mechanisms explaining this
association and to assess the burden of onchocerciasis-
associated epilepsy.
Onchocerciasis-Related Epilepsy
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information from published comparative studies. Details on these
standardisation processes are presented in the Supporting
Information to this article.
In addition, three studies were carried out in areas where
ivermectin treatment campaigns had been performed [6,18,19],
which affected the measure of the prevalence of O. volvulus
microfilaridermia. By using published studies on the effect of
community treatment with ivermectin we developed a model to
determine appropriate correction factors allowing us to estimate
the pre-treatment prevalence according to the number of
preceding treatment rounds (details given in Supporting Informa-
tion).
In the present paper, we assumed that if epilepsy were
associated with onchocerciasis, it might be due not only to the
presence of parasites in the cerebral tissue, but also to cicatricial
lesions persisting after the disappearance of the parasites after a
treatment. This is the case for epilepsy induced by other infectious
diseases (e.g. malaria [20]). Thus, we assumed that, in the present
study, ivermectin treatments had little or no effect on the epilepsy
of those patients who already suffered from this condition.
Ivermectin treatments might decrease incidence of epilepsy but
this effect would probably be perceptible after a number of years.
This is supported by observations made by Kaiser et al. [21] who
found that no major change in epilepsy incidence was observed
over 4 years after the start of annual ivermectin mass treatment.
Four of the 8 studies included in the present analysis referred to
the definition of epilepsy proposed by the International League
Against Epilepsy (ILAE) in 1993 [22] of ‘‘two or more unprovoked
seizures during the previous 2 years’’ whereas the remaining 4
studies used deviating definitions (Table 2). Characteristics of
neuro-epidemiological methods as used in the different studies are
presented in Table 2. Sampling procedures, methods for case
identification and confirmatory examinations were not uniform
and incompletely described in some studies. One study published
by Kipp et al. [19] reported a particularly high epilepsy prevalence
of 8% in the Kabarole district of western Uganda. However, for
the diagnosis of epilepsy this study was confined to a rapid
assessment of cases with suspected epilepsy without a more
extensive confirmatory examination. A later survey conducted in
the same onchocerciasis focus confirmed the diagnosis in only 61
(54%) out of 113 cases with suspected epilepsy [6]. If this ratio of
confirmed over suspected epilepsy patients is applied to the survey
of Kipp et al. [19], the crude epilepsy prevalence in the latter study
should be revised from 8% to 4.3% (8%60.54=4.3%).
Results
Available data
From the 1752 examined abstracts and research in the IENT
library, ten different studies reporting population-based surveys on
onchocerciasis and epilepsy prevalence were identified
[6,7,8,11,15,16,17,18,19,23] (Table 2). One study was excluded
because it originated from an area where control measures had
been carried out over 20 years within the Onchocerciasis Control
Programme (OCP) and the overall prevalence had decreased to a
low endemicity level at the time of the survey [10]. A second study
focusing on the clinical description of a series of epilepsy patients
in an onchocerciasis endemic area reported only an estimate of
epilepsy prevalence in the study area and was also not considered
[23]. A flowchart summary of the search is shown in Figure 1.
Data meeting the inclusion criteria consisted of 91 communities
from 8 distinct areas (2 in West Africa: Benin [16] and Nigeria
[18]; 2 in Central Africa: Cameroon [7] and Central African
Table 1. Methodological departures from the standard OCP procedure to assess onchocerciasis infection status and proposed
procedures to minimize the effect of these deviations on onchocerciasis prevalence.
Reference (country)
Deviation from standard OCP
method for evaluation of
onchocerciasis prevalence Rationale for correction/assumption
Method for correction (for reference
see Supporting Information)
Druet-Cabanac et al. [15]
(Central African Republic)
Prevalence assessed from nodule
palpation
Relationship between prevalence based on
nodule palpation and prevalence of
microfilaridermia
Relationship estimated through non
linear regression performed on data
collected in the same onchocerciasis
focus
Gbenou [16] (Benin) Prevalence assessed from skin snips
taken at either the scapula or at the
iliac crests
Relationship between prevalence based on
skin snips from the scapula and prevalence
based on skin snips from the iliac crests
Relationship estimated through linear
regression performed on published data
Gbenou [16](Benin) Skin snips incubated for about 30 min Relationship between the prevalence
obtained at 30 min and at 24 h incubation
time
Correction factor estimated from 16
villages with different endemicity levels
Kaiser et al. [6] (Uganda) Prevalence assessed in individuals
aged 10–23 years with a time of
residency in the study area between
10–19 years
Relationship between prevalence in the
general population and in the 10–19
years old population
Relationship estimated through linear
regression performed on data collected in
a similar onchocerciasis focus
Taylor et al. [17] (Tanzania) Prevalence assessed from 5–7 mm
skin snips taken at the lower anterior
portion of one leg
Distribution of microfilariae in the skin
of the shin is similar to that in the calf
Relationship estimated through linear
regression performed on published data
Taylor et al. [17] (Tanzania) Skin snips incubated for about 20 min In terms of sensitivity, a large skin snip
examined at 20 min similar to a standard
snip read at 30 min, then a 30 min to 24 h
correction is applied
Correction factor estimated from 16
villages with different endemicity levels
Newell et al. [8] (Burundi) Prevalence assessed from scarification Sensitivity to detect the presence of
microfilariae with this method similar to
the standard OCP method
No adjustment needed
doi:10.1371/journal.pntd.0000461.t001
Onchocerciasis-Related Epilepsy
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Tanzania [17] and Burundi [8,24]). The different surveys took
place between 1987 and 1997. Overall, 12 388 individuals were
examined for O. volvulus infection and a total of 905 subjects with
epilepsy were identified out of a screened population comprising
79 270 individuals (weighted average epilepsy prevalence: 1.14%).
Epilepsy and onchocerciasis prevalences were assessed from the
same population sample in two studies [16,18] whereas in the six
remaining studies [6,7,8,15,17,19] this was done on different
population samples in each community.
Relationship between epilepsy prevalence and that of
onchocerciasis
Figure 2 represents epilepsy prevalence versus onchocerciasis
prevalence, as reported in the documents retrieved during the
review of literature, for the 91 study communities included in the
analysis. Figure 3 represents the same data after applying the
correction factors to minimize obvious biases. Epilepsy prevalence
ranged from 0 to 8.7% and that of onchocerciasis from 1.4 to
100%. The fixed-effect logistic models fitted on observed and
corrected data sets indicate a significant association (all parameters
with p,0.0001) between onchocerciasis prevalence and epilepsy
prevalence (Table 3). Inclusion of a random-effect resulted in a
statistically significant improvement of the models (likelihood ratio
tests p,0.0001 for both models, Table 3). The random-effect
logistic model assessed on the corrected data provided slightly
lower estimates than when assessed from observed data, with the
respective corresponding odds-ratio: 1.042 (95%CI: 1.034–1.05)
and 1.044 (95%CI: 1.036–1.052). These values indicate that, on
average, epilepsy prevalence is increased by 0.4% for a 10%
increase in onchocerciasis prevalence.
However, as indicated by varying values of the random effect
parameter u (Table 4), the influence of onchocerciasis on epilepsy
differed between the studies. In particular, the random-effect
Table 2. Synopsis of neuro-epidemiological methodology used in studies on epilepsy prevalence in areas endemic for
onchocerciasis.
Reference (Country/No.
of study sites)
Assessment of total
population
Identification of
possible cases
Confirmatory examination/
staff qualification Epilepsy definition
Gbenou [16]
{ (Benin/5) Not specified Door-to-door, random sample of
households
Interview (non-standardized),
medical examination/Neurologist
$2 seizures*
Kabore ´ et al. [11]
* (Burkina
Faso/5)
Specific census Door-to-door, exhaustive in
population $15 year
Not specified/Neurologist $2 seizures
Newell et al. [8] (Burundi/1) Not specified Community leaders and staff of
health centre
Not specified/Health agents
supervised by medical doctor
$4 grand mal seizures in
preceding year if no AED
{
$1 grand mal seizure during
preceding year if AED
Boussinesq et al. [7]
(Cameroon/14)
National census Lists from community leaders
and systematic question on
epilepsy during parasitological
surveys
Interview (non-standardized)/
Medical doctor
$2 seizures during the previous 2
years
Druet-Cabanac et al. [15]
(CAR/42)
Not specified Door-to-door, exhaustive Not specified/Health agents
supervised by a medical doctor
Not specified
Dozie et al. [18] (Nigeria/13) Specific census Door-to-door, exhaustive
(all households)
Interview (non-standardized),
medical examination/Medical
doctor trained in paediatric
neurology
$2 seizures within the previous 2
years
Taylor et al. [17] (Tanzania/3) Not specified Mobilisation of population
(self-reporting)
Standardized questionnaire,
medical examination/Medical
doctor
$2 seizures during the previous
year
$1 seizure during the previous 5
years if AED
Kaiser et al. [6]
{ (Uganda/13) Specific census Door-to-door, exhaustive+
Self-reporting patients with
residency in study area
Standardized questionnaire,
medical examination/Medical
doctor trained in paediatric
neurology
$2 seizures within the previous 2
years
Kipp et al. [19] (Uganda/2) Not specified Door-to-door, random sample
of households
Not specified/Medical doctor $2 grand mal seizures during the
preceding year if no AED
$1 grand mal seizure during
preceding 5 years if AED
Ovuga et al. [23]
* (Uganda/1) Not specified Mobilisation of population
(self-reporting)
Not specified/Neurologist $2 seizures during the previous
year
$1 seizure during the previous 5
years if AED
*Study excluded: see text.
{Study site excluded:
a) Site ÆÆMasongora Northææ from Kaiser et al. [6], because only 8 individuals underwent parasitological examination.
b) Site ÆÆschoolææ from Gbenou [16], because this comprised schoolchildren from different parts of the study area and consequently was not considered as a proper site.
{AED: individuals under anti-epileptic drug treatment. CAR: Central African Republic.
doi:10.1371/journal.pntd.0000461.t002
Onchocerciasis-Related Epilepsy
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onchocerciasis on epilepsy was higher in the Nigeria study;
conversely, it was lower in the Cameroon and Central African
Republic studies (Table 4).
Sensitivity analysis showed that the significance of the
association between onchocerciasis prevalence and that of epilepsy
was not affected by omission of any of the studies (results not
shown).
Discussion
The present study was carried out in order to evaluate whether
the epilepsy prevalence in communities living in O. volvulus
endemic areas is related to the prevalence of onchocerciasis. All
available community-based surveys on this subject were used.
Throughout 91 communities distributed across 7 African coun-
tries, variation of epilepsy prevalence is associated with that of
onchocerciasis prevalence.
A recent review took an approach different from ours to analyse
epidemiological studies searching for a relationship between
onchocerciasis and epilepsy [25]. This review examined studies
from which it was possible to calculate the relative risk of epilepsy
in patients being infected with O. volvulus compared to the risk of
infection of inhabitants without epilepsy from the respective study
area. Inconsistent results were observed for nine African studies
providing sufficient data, with their respective relative risk
calculated at a broad range from 0.84 to 6.80. The common
relative risk of 1.21 (95% CL 0.99–1.47) for all studies was close to
the threshold of significance, suggesting a probable but weak risk
of epilepsy in onchocerciasis patients. Possibly, this review did not
yield a more pronounced association because it included studies
which were not originally designed as case-control studies. In areas
of low endemicity, the possible effect of onchocerciasis on epilepsy
in such an analysis will also be masked by the relatively higher
proportion of epilepsy cases due to alternative aetiologies.
A major difference between the review of Druet-Cabanac et al.
[25] and our analysis is that we introduced the quantitative
dimension of O. volvulus infection by defining the onchocerciasis
prevalence in a village as the risk factor. It has been demonstrated
that onchocerciasis prevalence is closely related to the intensity of
infection through a negative binomial relationship [26]. The
mathematical properties of this relationship implies that the higher
the prevalence, the higher the proportion of individuals with heavy
microfilarial loads in the population. In a previous study [7],
intensity of infection expressed as the microfilarial loads of patients
with epilepsy was 2 to 3 fold higher than those of controls matched
Figure 1. Flowchart summarizing the results of the search for papers on epilepsy potentially relating to onchocerciasis up to
February 2008.
doi:10.1371/journal.pntd.0000461.g001
Onchocerciasis-Related Epilepsy
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it has been found for ocular onchocercal pathology [27], intensity
of infection with O. volvulus is a key factor in the induction of
epilepsy. This would provide a further explanation as to why the
results of the previous review [25] gave a weaker degree of
significance to the association between epilepsy and onchocerciasis
than those obtained in our study.
The random effect included in the modelling indicates that the
influence of onchocerciasis on epilepsy varied between the studies.
This heterogeneity can be due to either differences in the
methodology used to assess the prevalence of onchocerciasis
and/or that of epilepsy, or to true biological differences
modulating the epilepsy/onchocerciasis association. In this
respect, there is some indication that the onchocerciasis prevalence
from the Nigerian study [18] may have been compromised by
inadequate correction. We were not able to determine with
precision the number of ivermectin treatments administered
before the parasitologic survey, nor the time interval between
the last ivermectin treatment and the survey. We assumed that the
parasitological assessment had been conducted at least 10 months
after the last treatment, which is a sufficient lapse of time for the
majority of infected patients to present again with microfilariae in
the skin. If the precise interval were shorter than our assumption,
the true initial prevalence of onchocerciasis would have been higher
than that used in our analysis. However, if one adds arbitrarily 20%
to all prevalence rates in this survey, one obtains similar estimates
for the random-effect model (a=27.174 (S.E.=0.301); b=0.041
(0.003); -2Log Likelihood=688.6), with the specific random-effect
of this study being no more significant (P=0.75).
In the Cameroonian study site, a 6-fold increase was found in
the mortality rate among individuals with epilepsy compared to
that in control individuals [28]. This significant mortality rate may
have resulted in an underestimation of epilepsy prevalence when it
was assessed through a cross-sectional survey. Should the mortality
rate of people with epilepsy be lower in the Nigerian area, epilepsy
prevalence in the latter would have been overestimated compared
to those obtained in Cameroon. Lastly, we do not discard the
possibility that other factors, such as O. volvulus strains with
differing pathogenic potential [29] or coinfection with other
pathogens, modulate the association between epilepsy and
onchocerciasis.
The assessment of epilepsy prevalence in the various studies of
the present analysis may have been influenced by the occurrence
of other endemic diseases known to be involved in the aetiology of
epilepsy [30]. Supposing a homogeneous distribution in the area of
such a competing aetiological factor, the increase of epilepsy
prevalence would be expected to comprise areas of low and high
onchocerciasis prevalence to the same extent but would not affect
an existing true association between epilepsy and onchocerciasis.
In contrast, a co-endemic disease following a local distribution
similar to that of onchocerciasis could reinforce (or weaken) this
association. Neurocysticercosis caused by cerebral cysts of the pork
tapeworm (Taenia solium) is considered a frequent cause for epilepsy
in many sub-Saharan regions [30,31] and it has been suggested
that, in areas co-endemic for onchocerciasis and cysticercosis,
epilepsy patients could be mistaken as having onchocerciasis-
related epilepsy when they may be suffering from neurocysticer-
cosis-derived epilepsy [32]. As far as information is available for
Figure 2. Epilepsy prevalence (as reported in the original studies) vs onchocerciasis prevalence. Error bars represent 95% exact
confidence intervals. Solid line: predicted relationship estimated by random-effect logistic regression; dashed lines: 95% confidence interval of the
model predictions.
doi:10.1371/journal.pntd.0000461.g002
Onchocerciasis-Related Epilepsy
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endemic in the study areas in Burundi and Cameroon [7,8,33],
but case-control studies from both these sites found a positive
correlation between epilepsy and onchocerciasis. In one study
from Uganda, serologic tests produced no evidence of a significant
infestation of the population with T. solium [6]. In view of the
results of the present analysis, we do not consider that
neurocysticercosis could be a confounding factor that would
produce a significant increase in epilepsy prevalence with
increasing onchocerciasis prevalence. For this to be the case, it
would be required that the distribution of neurocysticercosis (and
thus the pig raising habits of the local communities) would closely
follow the prevalence of onchocerciasis in the study areas of all
seven countries involved.
An extensive literature comparing the performance of the
various diagnostic methods of O. volvulus infection allowed us to
develop appropriate correction factors for onchocerciasis preva-
lence. However, no such information is available for epilepsy that
would have enabled us to do so for epilepsy prevalence. Strategies
to assess prevalence of epilepsy in developing countries were
developed in the 1980s [22,30,34,35]. Ideally, such studies should
follow a two-step protocol beginning with a population-wide door-
to-door survey in order to (i) provide a complete census defining
the sampling frame, (ii) assess epidemiologically relevant charac-
Figure 3. Epilepsy prevalence vs corrected onchocerciasis prevalence (see Supporting Information for details on correction
factors). Solid line: predicted relationship estimated by random-effect logistic regression; dashed lines: 95% confidence interval of the model
predictions.
doi:10.1371/journal.pntd.0000461.g003
Table 3. Parameters estimated (and standard errors) from logistic regression of epilepsy (y) on onchocerciasis (x) prevalences.
Dataset Model a (S.E.) b (S.E.) U (S.E.) -2LL
Observed
data
Epilepsy prevalence vs. onchocerciasis prevalence estimates with fixed-effect model 25.953 (0.136) 0.022 (0.002) Fixed to 0 902.8
Epilepsy prevalence vs. onchocerciasis prevalence estimates with random-effect model 26.745 (0.386) 0.043 (0.003) 0.831 (0.435) 711.8
Corrected
data
Epilepsy prevalence vs. onchocerciasis prevalence estimates with fixed-effect model 26.589 (0.308) 0.029 (0.002) Fixed to 0 761.2
Epilepsy prevalence vs. onchocerciasis prevalence estimates with random-effect model 27.048 (0.308) 0.041 (0.003) 0.308 (0.173) 690.2
The logistic model is expressed as y~ 1
1ze{ azbxzu ðÞ , where u is the random effect parameter; -2LL: -2 Log likelihood.
doi:10.1371/journal.pntd.0000461.t003
Onchocerciasis-Related Epilepsy
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epilepsy by use of a sensitive screening questionnaire. In a second
step, patients with possible epilepsy are then subjected to a
neurological and medical examination allowing confirmation or
rejection of the diagnosis. Only two studies included in the present
analysis can be regarded as having followed the recommended
protocol [6,18], but even these did not meet all requirements in
that they did not use a pre-tested sensitive screening tool for
patient identification but relied on a single screening question.
This may have led to an underestimation of epilepsy prevalence in
these studies. Procedures used for testing the population and
identifying possible epilepsy patients, and for confirming diagnosis
varied across the other studies and in a few instances these were
not clearly specified (Table 2). Comparison between studies was
also made difficult because no uniform definition for epilepsy was
used. The relative weakness in neurological methods can in part be
explained by the fact that most studies were initiated by
researchers involved in onchocerciasis control measures and by
the general scarcity of neurological expertise available in the
endemic areas [34,36].
The diversity of neuro-epidemiological methods may have
influenced epilepsy prevalence obtained in the different studies.
For instance, the use of community key informants for case
identification may have resulted in an underestimation [37],
whereas the lack of a confirmatory examination would have given
a falsely high prevalence. Although we have to consider these
effects as substantial, we were unable to express them quantita-
tively and our attempts to adjust epilepsy prevalence data were
restricted to the study of Kipp et al. [19]. However, despite
disparate neuro-epidemiological methods in use, we found epilepsy
prevalence closely related to onchocerciasis prevalence throughout
different African regions. It may be expected that this finding
would be even more significant if methods with better accuracy
were applied.
This is the first time that the relationship between the
prevalences of onchocerciasis and epilepsy has been quantitatively
assessed using available data collected at community level to
perform adequate statistical analysis. We found that in areas where
onchocerciasis is endemic, epilepsy prevalence increases with
onchocerciasis prevalence. This is in accordance with the results of
case-control studies and supports earlier anecdotal reports of
numerous researchers working in various endemic areas [38,39].
Because onchocerciasis is a disease affecting remote areas of
countries with limited resources for neurological research, some of
the studies carried out so far are influenced by methodological
shortcomings. Future studies should use established and compa-
rable protocols for neurological research. Possible research
questions to be addressed with available and appropriate methods
are: (i) the confirmation of the hitherto existing findings in other
endemic areas; (ii) the role of intensity of infection in inducing
epilepsy in areas not yet exposed to antifilarial treatment; (iii) the
clinical characterization and classification of epilepsy in the various
endemic areas; and (iv) the effect of long term onchocerciasis
control on epilepsy incidence and prevalence.
Supporting Information
Text S1 As the methods used to diagnose Onchocerca volvulus
infection varied between studies, the prevalences of onchocerciasis
were standardized using specifically developed tools. The details of
the standardization methods are presented in this appendix.
Found at: doi:10.1371/journal.pntd.0000461.s001 (0.14 MB
DOC)
Figure S1 Relationship between arcsine transformed onchocer-
ciasis prevalence in the general ($5 y.o. age group) population and
onchocerciasis prevalence in 10–19 y.o. subjects across 51 villages
located in the Mbam valley and continuous Lekie area
(Cameroon) [2,3,4]. The line represents linear regression esti-
mates.
Found at: doi:10.1371/journal.pntd.0000461.s002 (0.46 MB TIF)
Figure S2 O. volvulus microfilaridermia prevalence in communi-
ties from the Vina valley (North Cameroon) vs. onchocerciasis
prevalence assessed from nodule palpation in males aged 20 y.o.
and above [16]. Error bars represent 95% exact confidence limits
of mean prevalence.
Found at: doi:10.1371/journal.pntd.0000461.s003 (0.49 MB TIF)
Figure S3 Evolution of onchocerciasis prevalence with annual
ivermectin community treatments estimated through non linear
regression (Pn=P 06q
n) where Pn is the prevalence after n annual
treatments, P0 is the initial prevalence and 1-q is the annual
relative decrease assumed to be constant over time (q estimated as
0.926 [95%CI: 0.909–0.943]). The lines join the observations of a
same study, without any assumption on the mathematical pattern
of the decrease.
Found at: doi:10.1371/journal.pntd.0000461.s004 (0.42 MB TIF)
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